ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer

Ying Mei; Qinglei Hang; Hongqi Teng; Fan Yao; Mei-Kuang Chen; Mien-Chie Hung; Yutong Sun; Li Ma

doi:10.1016/j.gendis.2022.09.013

您当前的位置：

首页 >

文章列表页 >

ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer

Short communication | 更新时间：2023-08-29

- ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer
- ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer
- Genes & Diseases 2023年10卷第5期
- 作者机构：
  
  1. The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences,TX,Houston,USA,77030
  2. Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center,TX,Houston,USA,77030
  3. Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center,TX,Houston,USA,77030
  4. Hubei Hongshan Laboratory, College of Biomedicine and Health, College of Life Science and Technology, Huazhong Agricultural University,Hubei,Wuhan,China,430070
- 作者简介：
- 基金信息：
- DOI：10.1016/j.gendis.2022.09.013
  中图分类号：
- 纸质出版日期：2023，
  
  网络出版日期：2023-9-1，
扫描看全文
Ying Mei, Qinglei Hang, Hongqi Teng, 等. ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer[J]. Genes & Diseases, 2023,10(5).

Ying Mei, Qinglei Hang, Hongqi Teng, et al. ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer[J]. Genes & Diseases, 2023,10(5).
Ying Mei, Qinglei Hang, Hongqi Teng, 等. ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer[J]. Genes & Diseases, 2023,10(5). DOI： 10.1016/j.gendis.2022.09.013.

Ying Mei, Qinglei Hang, Hongqi Teng, et al. ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer[J]. Genes & Diseases, 2023,10(5). DOI： 10.1016/j.gendis.2022.09.013.

摘要

Abstract

关键词

Keywords

references

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据

ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer

ZRANB1 is an NBS1 deubiquitinase and a potential target to overcome radioresistance and PARP inhibitor resistance in triple-negative breast cancer

DOI：10.1016/j.gendis.2022.09.013

摘要

Abstract

关键词

Keywords

references